Please provide your email address to receive an email when new articles are posted on . In the United States, the annual rate of growth in incident patients with end-stage kidney disease has slowed.

Chlorthalidone appears as effective as hydrochlorothiazide in slowing progression to chronic kidney disease among patients with hypertension. Kidney function decline occurs no faster when patients ...

Understanding eGFR and uPCR is vital for managing IgA nephropathy to predict kidney health, guide treatment, and work ...

New study findings “are critically important in patient counseling and surgical planning, particularly for patients with risk factors for renal deterioration,” according to investigators. A lower ...

Patients with immunoglobin A nephropathy who reached complete remission of proteinuria with sparsentan had greater eGFR ...

This Rare Disease Day, observed on Feb. 28 worldwide, the American Kidney Fund is committed to improving the understanding of rare kidney diseases by providing educational resources.

Medically reviewed by David Ozeri, MD Complement 3 glomerulopathy (C3G) is a rare kidney disorder—in many cases, the exact ...

Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...

Pregnancy can have a big impact on a woman’s body. For Marrian Bell, 35, it affected her kidney function as she fought to ...

Data from up to 42 months of treatment reinforce lucerastat’s potential as a first-in-class oral substrate reduction therapy addressing key unmet needs across the Fabry populationThe company is ...